FINWIRES · TerminalLIVE
FINWIRES

Shyndec Pharma Gets Registration Certificate for Ibrutinib Capsules

By

Shanghai Shyndec Pharmaceutical (SHA:600420) received a drug registration certificate from China's National Medical Products Administration for ibrutinib capsules, according to a Shanghai bourse filing on Friday.

The drug is used to treat cancers such as lymphoma and Waldenström Macroglobulinemia.

The pharmaceutical company invested 15.6 million yuan into the drug's research and development.

Related Articles

Asia

Welspun Corp's Consolidated Profit Slumps in Fiscal Q4; Shares Fall 4%

Welspun Corp (NSE:WELCORP, BOM:532144) consolidated attributable net profit declined to 3.70 billion rupees in the fiscal fourth quarter ended March 31 from 6.98 billion rupees a year ago, according to a filing to the Indian stock exchanges on Thursday.Shares of the pipes manufacturer fell over 4% in Friday's trade.Earnings per share contracted to 14.04 rupees from 26.50 rupees a year earlier.Revenue from operations in fiscal Q4 increased to 43.1 billion rupees from 39.2 billion rupees a year ago.The company's board of directors recommended a final dividend of 5 rupees per share for the financial year ended March 31.

$BOM:532144$NSE:WELCORP
Asia

Market Chatter: Korea Gas Signs 10-Year LNG Purchase Agreement with British Oil & Gas Firm BP

Korea Gas (KRX:036460) signed a 10-year contract with British oil and gas company BP plc (LON:BP) to purchase 700,000 tons of liquefied natural gas (LNG) on an annual basis, beginning in 2028, Yonhap News reported Friday.The agreement follows a separate agreement signed by Korea Gas last year to import 3.3 million tons of LNG annually from the US beginning in 2028, the report said.Korea Gas said the latest contract will help diversify energy supply sources and stabilize gas prices amid prolonged Middle East tensions, it said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$KRX:036460$LON:BP
Asia

Shanghai M&G Stationery's Chairman Proposed Shares Buyback of Up to 1 Billion Yuan

Shanghai M&G Stationery (SHA:603899) Chairman Chen Huwen proposed to repurchase shares worth between 500 million yuan and 1 billion yuan, according to a Shanghai bourse filing on Friday.The share buyback will be implemented within 12 months after the board of directors' approval.The stationery manufacturer's shares closed 6% higher.

$SHA:603899